Eir Ven­tures tops up life sci­ences fund with $138M for Nordic biotechs

Swedish ven­ture cap­i­tal man­ag­er Eir Ven­tures has round­ed up a to­tal of $138 mil­lion for its life sci­ences fund Eir Ven­tures I AB.

The fund — launched just last year — is the firm’s first ded­i­cat­ed life sci­ences ven­ture cap­i­tal fund, ac­cord­ing to a com­pa­ny state­ment. Backed by a syn­di­cate of in­vestors such as the Eu­ro­pean In­vest­ment Fund (EIF), No­vo Hold­ings, and new blue-chip in­vestors such as the Sus­tain­able De­vel­op­ment Um­brel­la Fund (SDUF), the fund claims to in­vest in life sci­ence com­pa­nies “with prod­ucts and tech­nolo­gies ad­dress­ing sig­nif­i­cant un­met med­ical needs,” ac­cord­ing to a com­pa­ny state­ment.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER